Artificial intelligence is increasingly embedded in clinical workflows, from early disease detection to streamlined care coordination. The true measure of its value lies in whether it improves patient outcomes and helps clinicians deliver care more efficiently.
UpToDate has long served as a trusted source of evidence-based clinical information, authored and reviewed by thousands of physicians. A new partnership unveiled at the HLTH conference in Las Vegas is now bringing that resource directly into the workflows clinicians use to coordinate care for their most critically ill patients.
Viz.ai and Wolters Kluwer Health, owner of the UpToDate platform, will integrate UpToDate Expert AI directly into Viz.ai One. The San Francisco-based company’s AI-powered care coordination and disease detection platform is already deployed in 2,000 hospitals across the United States, helping clinicians identify patients who need faster intervention through real-time disease detection and synchronized care-team communication. Headquartered in Alphen aan den Rijn, the Netherlands, Wolters Kluwer Health serves customers in more than 180 countries with information solutions, software, and services for healthcare professionals and other industries.
The integration enables medical providers to pose clinical questions and receive evidence-based answers drawn from UpToDate, informed by individual patient data from Viz.ai—all without leaving their existing workflow. The tool enters a competitive field that includes AI-powered resources such as OpenEvidence, a clinical decision support platform and medical search engine.
The collaboration rests on a straightforward premise: delivering the right information to the right clinicians faster can produce significant benefits for patients.
This is especially critical in time-sensitive conditions such as stroke. When blood flow to the brain is interrupted, every minute lost can worsen outcomes. Rapid treatment can preserve long-term function and potentially save lives.
A 2023 study published in the American Journal of Neuroradiology examined outcomes after Viz.ai was implemented at a comprehensive stroke center. Researchers found that door-to-groin times—the interval between a patient’s arrival and catheter insertion for thrombectomy—fell by 39% for patients with large vessel occlusions arriving during off-hours. The authors credited the improvement to quicker access to imaging and more coordinated communication among care team members.
According to Dr. Andrew Ibrahim, chief clinical officer at Viz.ai, the next step is to place the clinical information providers already seek into a single platform, tailored specifically to the patient in front of them.
“Embedding UpToDate Expert AI inside Viz.ai One fundamentally changes when and how clinicians use clinical evidence,” Ibrahim said in an email. “Clinicians don’t have to stop what they’re doing to look it up.”
Ibrahim emphasized that the tool does not make clinical decisions; rather, it supplies clinicians with the information needed to manage timely and effective care, including transparent sourcing details for in-app content.
“Keeping the sources visible is deliberate,” Ibrahim said. “It encourages physicians to examine the reasoning rather than simply accept an answer. There is no shortage of AI tools that will provide an answer, but UpToDate’s is grounded in evidence that physicians have trusted and relied on for decades.”
For busy clinicians and strained hospital systems, today’s technologies offer more than convenience or speed. When used thoughtfully, they can deliver better outcomes and a tangible impact on patient lives.

